Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study
University of Sao Paulo
40 participants
Mar 23, 2015
INTERVENTIONAL
Conditions
Summary
This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.
Eligibility
Inclusion Criteria1
- \- acute Vogt-Koyanagi-Harada disease
Exclusion Criteria2
- non collaborative patient
- minimum one-year follow-up
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Early high-dose corticosteroid and immunosuppressive therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03399175